Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 378

1.

Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.

Sorkness CA, Lemanske RF Jr, Mauger DT, Boehmer SJ, Chinchilli VM, Martinez FD, Strunk RC, Szefler SJ, Zeiger RS, Bacharier LB, Bloomberg GR, Covar RA, Guilbert TW, Heldt G, Larsen G, Mellon MH, Morgan WJ, Moss MH, Spahn JD, Taussig LM; Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute.

J Allergy Clin Immunol. 2007 Jan;119(1):64-72. Epub 2006 Nov 30. Erratum in: J Allergy Clin Immunol. 2007 Aug;120(2):285.

PMID:
17140647
[PubMed - indexed for MEDLINE]
2.

Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.

Zeiger RS, Szefler SJ, Phillips BR, Schatz M, Martinez FD, Chinchilli VM, Lemanske RF Jr, Strunk RC, Larsen G, Spahn JD, Bacharier LB, Bloomberg GR, Guilbert TW, Heldt G, Morgan WJ, Moss MH, Sorkness CA, Taussig LM; Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute.

J Allergy Clin Immunol. 2006 Jan;117(1):45-52.

PMID:
16387583
[PubMed - indexed for MEDLINE]
3.

Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.

Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.

Clin Ther. 2008 Aug;30(8):1492-504. doi: 10.1016/j.clinthera.2008.07.018.

PMID:
18803991
[PubMed - indexed for MEDLINE]
4.

Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma.

Sheth K, Borker R, Emmett A, Rickard K, Dorinsky P.

Pharmacoeconomics. 2002;20(13):909-18.

PMID:
12381242
[PubMed - indexed for MEDLINE]
6.

Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.

O'Connor RD, Nelson H, Borker R, Emmett A, Jhingran P, Rickard K, Dorinsky P.

Pharmacoeconomics. 2004;22(12):815-25.

PMID:
15294013
[PubMed - indexed for MEDLINE]
7.

Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.

Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, Zeiger RS, Larsen G, Spahn JD, Bacharier LB, Bloomberg GR, Guilbert TW, Heldt G, Morgan WJ, Moss MH, Sorkness CA, Taussig LM.

J Allergy Clin Immunol. 2005 Feb;115(2):233-42.

PMID:
15696076
[PubMed - indexed for MEDLINE]
8.

Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.

Boonsawat W, Goryachkina L, Jacques L, Frith L.

Clin Drug Investig. 2008;28(2):101-11.

PMID:
18211118
[PubMed - indexed for MEDLINE]
9.

Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.

Ilowite J, Webb R, Friedman B, Kerwin E, Bird SR, Hustad CM, Edelman JM.

Ann Allergy Asthma Immunol. 2004 Jun;92(6):641-8.

PMID:
15237766
[PubMed - indexed for MEDLINE]
10.

Inhaled corticosteroids or montelukast as the preferred primary long-term treatment for pediatric asthma?

Jartti T.

Eur J Pediatr. 2008 Jul;167(7):731-6. doi: 10.1007/s00431-007-0644-3. Epub 2008 Jan 24. Erratum in: Eur J Pediatr. 2008 Jul;167(7):737-8.

PMID:
18214538
[PubMed - indexed for MEDLINE]
11.

Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.

Kavuru M, Melamed J, Gross G, Laforce C, House K, Prillaman B, Baitinger L, Woodring A, Shah T.

J Allergy Clin Immunol. 2000 Jun;105(6 Pt 1):1108-16.

PMID:
10856143
[PubMed - indexed for MEDLINE]
12.

Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial.

Zeiger RS, Bird SR, Kaplan MS, Schatz M, Pearlman DS, Orav EJ, Hustad CM, Edelman JM.

Am J Med. 2005 Jun;118(6):649-57.

PMID:
15922697
[PubMed - indexed for MEDLINE]
13.

Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma.

Pearlman DS, White MV, Lieberman AK, Pepsin PJ, Kalberg C, Emmett A, Bowers B, Rickard KA, Dorinsky P.

Ann Allergy Asthma Immunol. 2002 Feb;88(2):227-35.

PMID:
11868930
[PubMed - indexed for MEDLINE]
14.

Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.

Rand C, Bilderback A, Schiller K, Edelman JM, Hustad CM, Zeiger RS; MIAMI Study Research Group.

J Allergy Clin Immunol. 2007 Apr;119(4):916-23. Epub 2007 Mar 8.

PMID:
17349681
[PubMed - indexed for MEDLINE]
15.

Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).

Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M; Viani-Initial Study Group.

Eur J Med Res. 2002 Jan 29;7(1):1-7.

PMID:
11827834
[PubMed - indexed for MEDLINE]
16.

Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial.

Busse W, Raphael GD, Galant S, Kalberg C, Goode-Sellers S, Srebro S, Edwards L, Rickard K; Fluticasone Proprionate Clinical Research Study Group.

J Allergy Clin Immunol. 2001 Mar;107(3):461-8.

PMID:
11240946
[PubMed - indexed for MEDLINE]
17.

Comparison of add-on therapy to inhaled fluticasone propionate in children with asthma: residual volume and exhaled nitric oxide as outcome measures.

Verini M, Peroni DG, Piacentini GL, Nicodemo A, Rossi N, Bodini A, Chiarelli F, Boner AL.

Allergy Asthma Proc. 2007 Nov-Dec;28(6):691-4. doi: 10.2500/aap.2007.28.3054.

PMID:
18201433
[PubMed - indexed for MEDLINE]
18.

Role of add-on zileuton on total exhaled, large airway, and small airway/alveolar nitric oxide in moderate-severe persistent adult asthmatics on fluticasone 250 microg/Salmeterol 50 microg.

Gelb AF, Taylor CF, Simmons M, Shinar C.

Pulm Pharmacol Ther. 2009 Dec;22(6):516-21. doi: 10.1016/j.pupt.2009.05.003. Epub 2009 May 23.

PMID:
19467341
[PubMed - indexed for MEDLINE]
19.

Adherence to asthma controller medication regimens.

Stempel DA, Stoloff SW, Carranza Rosenzweig JR, Stanford RH, Ryskina KL, Legorreta AP.

Respir Med. 2005 Oct;99(10):1263-7. Epub 2005 Apr 12.

PMID:
16140227
[PubMed - indexed for MEDLINE]
Free Article
20.

Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast.

Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, Knobil K.

J Allergy Clin Immunol. 2000 Dec;106(6):1088-95. Erratum in: J Allergy Clin Immunol 2001 Apr;107(4):614.

PMID:
11112891
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk